{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:48:01Z","timestamp":1793836081928,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00508-018-1318-z","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:02:54Z","timestamp":1516885374000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis"],"prefix":"10.1007","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-2040","authenticated-orcid":false,"given":"Marko","family":"Lucijanic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Veletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Rahelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlatko","family":"Pejsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Skelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Livun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Marija","family":"Tupek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajana","family":"Stoos-Veic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Lucijanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Maglicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajko","family":"Kusec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"20","key":"1318_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et\u00a0al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood."},{"issue":"9\u201310","key":"1318_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00508-016-1120-8","volume":"129","author":"T Sliwa","year":"2017","unstructured":"Sliwa T, Beham-Schmid C, Burgstaller S, et al. Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement. Wien Klin Wochenschr. 2017;129(9\u201310):293\u2013302.","journal-title":"Wien Klin Wochenschr"},{"issue":"14","key":"1318_CR3","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a\u00a0trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood. 2012;119(14):3219\u201325.","journal-title":"Blood."},{"issue":"24","key":"1318_CR4","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1200\/JCO.2012.42.1925","volume":"30","author":"M Hultcrantz","year":"2012","unstructured":"Hultcrantz M, Kristinsson SY, Andersson TM, et al. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a\u00a0population-based study. J\u00a0Clin Oncol. 2012;30(24):2995\u20133001.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1318_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.mayocp.2017.05.010","volume":"92","author":"M Yogarajah","year":"2017","unstructured":"Yogarajah M, Tefferi A. Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome. Mayo Clin Proc. 2017;92(7):1118\u201328.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1318_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.leu.2404914","volume":"22","author":"G Barosi","year":"2008","unstructured":"Barosi G, Mesa RA, Thiele J, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a\u00a0consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia. 2008;22(2):437\u20138.","journal-title":"Leukemia"},{"issue":"13","key":"1318_CR7","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","volume":"113","author":"F Cervantes","year":"2009","unstructured":"Cervantes F, Dupriez B, Pereira A, et\u00a0al. New prognostic scoring system for primary myelofibrosis based on a\u00a0study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2009;113(13):2895\u2013901.","journal-title":"Blood."},{"issue":"9","key":"1318_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"F Passamonti","year":"2010","unstructured":"Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a\u00a0study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 2010;115(9):1703\u20138.","journal-title":"Blood."},{"issue":"6","key":"1318_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0115426588003006219","volume":"3","author":"JA Tayek","year":"1988","unstructured":"Tayek JA. Albumin synthesis and nutritional assessment. Nutr Clin Pract. 1988;3(6):219\u201321.","journal-title":"Nutr Clin Pract"},{"issue":"10","key":"1318_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.nut.2009.08.026","volume":"26","author":"RA Fock","year":"2010","unstructured":"Fock RA, Blatt SL, Beutler B, et al. Study of lymphocyte subpopulations in bone marrow in a\u00a0model of protein-energy malnutrition. Nutrition. 2010;26(10):1021\u20138.","journal-title":"Nutrition"},{"issue":"3","key":"1318_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/S0102-67202015000300012","volume":"28","author":"NP Rocha","year":"2015","unstructured":"Rocha NP, Fortes RC. Total lymphocyte count and serum albumin as predictors of nutritional risk in surgical patients. Arq Bras Cir Dig. 2015;28(3):193\u20136.","journal-title":"Arq Bras Cir Dig"},{"issue":"6","key":"1318_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/eat.20417","volume":"40","author":"H Saito","year":"2007","unstructured":"Saito H, Nomura K, Hotta M, Takano K. Malnutrition induces dissociated changes in lymphocyte count and subset proportion in patients with anorexia nervosa. Int J Eat Disord. 2007;40(6):575\u20139.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"1318_CR13","first-page":"272","volume":"4","author":"S Bharadwaj","year":"2016","unstructured":"Bharadwaj S, Ginoya S, Tandon P, et\u00a0al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep. 2016;4(4):272\u201380.","journal-title":"Gastroenterol. Rep."},{"issue":"8","key":"1318_CR14","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.3390\/nu9080829","volume":"9","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Pereira SL, Luo M, Matheson EM. Evaluation of blood Biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients. 2017;9(8):E829.","journal-title":"Nutrients"},{"issue":"1","key":"1318_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/014860717700100101","volume":"1","author":"GL Blackburn","year":"1977","unstructured":"Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977;1(1):11\u201322.","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"9","key":"1318_CR16","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001\u20135.","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"11\u201312","key":"1318_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00508-016-1077-7","volume":"129","author":"V Perisa","year":"2017","unstructured":"Perisa V, Zibar L, Knezovic A, Perisa I, Sincic-Petricevic J, Aurer I. Prognostic nutritional index as a\u00a0predictor of prognosis in patients with diffuse large B cell lymphoma. Wien Klin Wochenschr. 2017;129(11\u201312):411\u20139.","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"1318_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00432-014-1714-3","volume":"140","author":"K Sun","year":"2014","unstructured":"Sun K, Chen S, Xu J, Li G, He Y. The prognostic significance of the prognostic nutritional index in cancer: a\u00a0systematic review and meta-analysis. J\u00a0Cancer Res Clin Oncol. 2014;140(9):1537\u201349.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1318_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.athoracsur.2017.01.085","volume":"104","author":"S Okada","year":"2017","unstructured":"Okada S, Shimada J, Kato D, Tsunezuka H, Teramukai S, Inoue M. Clinical significance of prognostic nutritional index after surgical treatment in lung cancer. Ann Thorac Surg. 2017;104(1):296\u2013302.","journal-title":"Ann Thorac Surg"},{"issue":"36","key":"1318_CR20","doi-asserted-by":"crossref","first-page":"58543","DOI":"10.18632\/oncotarget.10148","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Gao P, Chen X, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a\u00a0retrospective cohort study and a\u00a0meta-analysis. Oncotarget. 2016;7(36):58543\u201352.","journal-title":"Oncotarget"},{"issue":"18","key":"1318_CR21","doi-asserted-by":"publisher","first-page":"e3539","DOI":"10.1097\/MD.0000000000003539","volume":"95","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kim HI, Kim YN, et al. Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine (Baltimore). 2016;95(18):e3539.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1318_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/01635581.2016.1250921","volume":"69","author":"SH Lee","year":"2017","unstructured":"Lee SH, Chung MJ, Kim B, et\u00a0al. The significance of the prognostic nutritional index for all stages of pancreatic cancer. Nutr Cancer. 2017;69(3):512\u20139.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1318_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.17925\/OHR.2011.07.1.61","volume":"7","author":"RM Scherber","year":"2011","unstructured":"Scherber RM, Mesa RA. Relevance of weight loss, splenomegaly, and hypocholesterolemia in the treatment of myeloproliferative neoplasms\u2014implications for a\u00a0JAK2 inhibitor era. Oncol Hematol Rev. 2011;7(1):61\u20133.","journal-title":"Oncol Hematol Rev"},{"issue":"2","key":"1318_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1034\/j.1600-0609.2000.90262.x","volume":"65","author":"F Cervantes","year":"2000","unstructured":"Cervantes F, Hernandez-Boluda JC, Villamor N, Serra A, Montserrat E. Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis. Eur J Haematol. 2000;65(2):104\u20138.","journal-title":"Eur J Haematol"},{"issue":"8","key":"1318_CR25","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90(8):1128\u201332.","journal-title":"Haematologica"},{"issue":"9464","key":"1318_CR26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et\u00a0al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054\u201361.","journal-title":"Lancet"},{"issue":"7","key":"1318_CR27","doi-asserted-by":"publisher","first-page":"e103511","DOI":"10.1371\/journal.pone.0103511","volume":"9","author":"C Bilbao-Sieyro","year":"2014","unstructured":"Bilbao-Sieyro C, Santana G, Moreno M, et al. High resolution melting analysis: a\u00a0rapid and accurate method to detect CALR mutations. PLoS ONE. 2014;9(7):e103511.","journal-title":"PLoS ONE"},{"issue":"12","key":"1318_CR28","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/leu.2011.161","volume":"25","author":"A Pardanani","year":"2011","unstructured":"Pardanani A, Guglielmelli P, Lasho TL, et\u00a0al. Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients. Leukemia. 2011;25(12):1834\u20139.","journal-title":"Leukemia"},{"issue":"2","key":"1318_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.11613\/BM.2012.018","volume":"22","author":"M Lucijanic","year":"2012","unstructured":"Lucijanic M, Petrovecki M. Analysis of censored data. Biochem Med. 2012;22(2):151\u20135.","journal-title":"Biochem Med"},{"issue":"1","key":"1318_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.11613\/BM.2017.002","volume":"27","author":"M Lucijanic","year":"2017","unstructured":"Lucijanic M, Skelin M, Lucijanic T. Survival analysis, more than meets the eye. Biochem Med. 2017;27(1):14\u20138.","journal-title":"Biochem Med"},{"issue":"1","key":"1318_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3325\/cmj.2016.57.77","volume":"57","author":"M Lucijanic","year":"2016","unstructured":"Lucijanic M. Survival analysis in clinical practice: analyze your own data using an Excel workbook. Croat Med\u00a0J. 2016;57(1):77\u20139.","journal-title":"Croat Med J"},{"issue":"21","key":"1318_CR32","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.2174\/092986711796391633","volume":"18","author":"J Nunez","year":"2011","unstructured":"Nunez J, Minana G, Bodi V, et\u00a0al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226\u201333.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1318_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.clml.2014.12.008","volume":"15","author":"RA Mesa","year":"2015","unstructured":"Mesa RA, Verstovsek S, Gupta V, et al. Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I. Clin Lymphoma Myeloma Leuk. 2015;15(4):214\u2013221.e1.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"1318_CR34","first-page":"1473","volume":"32","author":"T Gluck","year":"2005","unstructured":"Gluck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J\u00a0Rheumatol. 2005;32(8):1473\u201380.","journal-title":"J Rheumatol"},{"issue":"1","key":"1318_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajh.24572","volume":"92","author":"N Polverelli","year":"2017","unstructured":"Polverelli N, Breccia M, Benevolo G, et\u00a0al. Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients. Am J Hematol. 2017;92(1):37\u201341.","journal-title":"Am J Hematol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-018-1318-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T03:14:15Z","timestamp":1603682055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-018-1318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":35,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s00508-018-1318-z","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"M.\u00a0Lucijanic, I.\u00a0Veletic, D.\u00a0Rahelic, V.\u00a0Pejsa, D.\u00a0Cicic, M.\u00a0Skelin, A.\u00a0Livun, K.M.\u00a0Tupek, T.\u00a0Stoos-Veic, T.\u00a0Lucijanic, A.\u00a0Maglicic, and R.\u00a0Kusec declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all subjects in whom molecular studies were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}